POTEE mutation as a potential predictive biomarker for immune checkpoint inhibitors in lung adenocarcinoma
{{output}}
Precise selection of patients who could benefit from immune checkpoint inhibitors (ICIs) is an important challenge for immunotherapy in lung cancer. POTEE (POTE Ankyrin Domain Family Member E) is a member of one primate-specific gene family which have been ide... ...
